Published in J Biol Chem on February 05, 2010
Molecular functions of metallothionein and its role in hematological malignancies. J Hematol Oncol (2012) 0.93
The Functions of Metallothionein and ZIP and ZnT Transporters: An Overview and Perspective. Int J Mol Sci (2016) 0.81
A PU.1 suppressive target gene, metallothionein 1G, inhibits retinoic acid-induced NB4 cell differentiation. PLoS One (2014) 0.75
The differentiation effect of low-dose cytosine arabinoside is disturbed in PU.1-knockdown K562 cells. Biomed Rep (2014) 0.75
Multiple DNA-binding modes for the ETS family transcription factor PU.1. J Biol Chem (2017) 0.75
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell (1990) 8.00
Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol (1998) 7.61
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science (1994) 7.60
Intermediate filaments: a chemically heterogeneous, developmentally regulated class of proteins. Annu Rev Biochem (1982) 4.54
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet (2004) 4.45
Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions. Mol Cell Biol (1997) 3.77
Coding sequence and growth regulation of the human vimentin gene. Mol Cell Biol (1986) 2.34
Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells. Nat Genet (2006) 2.10
Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res (2003) 1.94
Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia. Blood (2003) 1.87
Highly methylated genes in colorectal neoplasia: implications for screening. Cancer Epidemiol Biomarkers Prev (2007) 1.67
Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure. Mol Cell Biol (2002) 1.64
Deletion of an AML1-ETO C-terminal NcoR/SMRT-interacting region strongly induces leukemia development. Proc Natl Acad Sci U S A (2004) 1.60
Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B. Blood (1995) 1.60
The IL-7 receptor controls the accessibility of the TCRgamma locus by Stat5 and histone acetylation. Immunity (2001) 1.47
Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b. Oncogene (2006) 1.35
Functional analysis and growth factor regulation of the human vimentin promoter. Mol Cell Biol (1987) 1.33
Isoform-specific expression of metallothionein mRNA in the developing and adult human kidney. Toxicol Lett (1996) 1.23
JDP2, a repressor of AP-1, recruits a histone deacetylase 3 complex to inhibit the retinoic acid-induced differentiation of F9 cells. Mol Cell Biol (2002) 1.18
Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes. J Pharmacol Exp Ther (2001) 1.13
Escape mechanisms from antibody therapy to lymphoma cells: downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylation. Biochem Biophys Res Commun (2009) 1.12
The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression. Genes Cells (2007) 1.12
Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression. Oncogene (2003) 1.09
The c-Jun dimerization protein 2 inhibits cell transformation and acts as a tumor suppressor gene. J Biol Chem (2003) 1.06
Metallothionein is a potential negative regulator of apoptosis. Toxicol Sci (2003) 1.01
Structure and expression of the human metallothionein-IG gene. Differential promoter activity of two linked metallothionein-I genes in response to heavy metals. J Biol Chem (1988) 1.00
In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression. Oncogene (2001) 0.96
Over-expression of Flt3 induces NF-kappaB pathway and increases the expression of IL-6. Leuk Res (2005) 0.93
Caspase-resistant vimentin suppresses apoptosis after photodynamic treatment with a silicon phthalocyanine in Jurkat cells. Arch Biochem Biophys (2001) 0.91
The Flt3 internal tandem duplication mutant inhibits the function of transcriptional repressors by blocking interactions with SMRT. Blood (2004) 0.91
Inverse correlation between Flt3 and PU.1 expression in acute myeloblastic leukemias. Leuk Res (2005) 0.87
The hematopoietic transcription factor PU.1 is downregulated in human multiple myeloma cell lines. Blood (1995) 0.86
Prognostic significance of metallothionein in B-cell lymphomas. Blood (2006) 0.86
CD34, RAB20, PU.1 and GFI1 mRNA expression in myelodysplastic syndrome. Int J Lab Hematol (2008) 0.86
AML1B transcriptional repressor function is impaired by the Flt3-internal tandem duplication. Br J Haematol (2005) 0.85
Identification of annexin 1 as a PU.1 target gene in leukemia cells. Leuk Res (2009) 0.83
Cell cycle analysis of human peripheral blood T lymphocytes in long-term culture. Exp Cell Res (1987) 0.81
Growth-regulated expression of vimentin in hamster fibroblasts is a result of increased transcription. J Cell Biochem (1992) 0.80
Prognostic significance of PU.1 in follicular lymphoma. J Pathol (2006) 0.79
Multiple resistance mechanisms in acute nonlymphoblastic leukemia (ANLL). Anticancer Res (1998) 0.78
Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain. Mol Cell (2003) 2.20
Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival. Clin Cancer Res (2012) 1.84
Induction of triggering receptor expressed on myeloid cells 1 in murine resident peritoneal macrophages by monosodium urate monohydrate crystals. Arthritis Rheum (2006) 1.73
Predictive factors improving survival after gastrectomy in gastric cancer patients with peritoneal carcinomatosis. World J Surg (2010) 1.72
Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. J Exp Med (2003) 1.69
Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma. World J Surg (2008) 1.65
Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma. Cancer Sci (2009) 1.64
Impact of intestinal colonization and invasion on the Entamoeba histolytica transcriptome. Mol Biochem Parasitol (2006) 1.55
All-trans retinoic acid and a novel synthetic retinoid tamibarotene (Am80) differentially regulate CD38 expression in human leukemia HL-60 cells: possible involvement of protein kinase C-delta. J Leukoc Biol (2011) 1.50
Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan. Ann Surg Oncol (2011) 1.46
Relationship between the histological type of initial lesions and the risk for the development of remnant gastric cancers after gastrectomy for synchronous multiple gastric cancers. World J Surg (2010) 1.45
A novel protein kinase B (PKB)/AKT-binding protein enhances PKB kinase activity and regulates DNA synthesis. J Biol Chem (2005) 1.40
Clinicopathological analysis of primary adrenal diffuse large B-cell lymphoma: effectiveness of rituximab-containing chemotherapy including central nervous system prophylaxis. Exp Hematol Oncol (2013) 1.35
Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer. Int J Oncol (2009) 1.29
Impact of tumor-associated macrophages on invasive ductal carcinoma of the pancreas head. Cancer Sci (2012) 1.25
Survival benefits of portal vein resection for pancreatic cancer. Am J Surg (2003) 1.22
Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells. Int Immunol (2005) 1.21
Long-term survival in two cases of resected gastric metastasis of pulmonary pleomorphic carcinoma. J Thorac Oncol (2008) 1.20
Regulation of the plasma cell transcription factor Blimp-1 gene by Bach2 and Bcl6. Int Immunol (2008) 1.14
Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis. Int J Hematol (2010) 1.11
Induction of human humoral immune responses in a novel HLA-DR-expressing transgenic NOD/Shi-scid/γcnull mouse. Int Immunol (2012) 1.10
Recent advances in crystal-induced acute inflammation. Curr Opin Rheumatol (2007) 1.10
Characterization of the organic cation transporter SLC22A16: a doxorubicin importer. Biochem Biophys Res Commun (2005) 1.08
Laparoscopic proximal gastrectomy with jejunal interposition for gastric cancer in the proximal third of the stomach: a retrospective comparison with open surgery. Surg Endosc (2012) 1.06
Apoptosis of intestinal crypt epithelium after Cryptosporidium parvum infection. J Infect Chemother (2003) 1.06
Extrahepatic spread from hepatocellular carcinoma: who are candidates for aggressive anti-cancer treatment? Jpn J Clin Oncol (2004) 1.05
Reversible bone marrow dysplasia in patients with systemic lupus erythematosus. Intern Med (2008) 1.05
Detail histologic analysis of nerve plexus invasion in invasive ductal carcinoma of the pancreas and its prognostic impact. Am J Surg Pathol (2007) 1.04
Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2013) 1.04
Hepatocyte nuclear factor 4alpha contributes to thyroid hormone homeostasis by cooperatively regulating the type 1 iodothyronine deiodinase gene with GATA4 and Kruppel-like transcription factor 9. Mol Cell Biol (2008) 1.04
Inhibition of monosodium urate monohydrate crystal-induced acute inflammation by retrovirally transfected prostaglandin D synthase. Arthritis Rheum (2003) 1.04
IL-10 controls Th2-type cytokine production and eosinophil infiltration in a mouse model of allergic airway inflammation. Immunobiology (2010) 1.03
COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo. Lab Invest (2003) 1.00
Prevention of postoperative pancreatic fistula after total gastrectomy. World J Surg (2008) 1.00
Increased expression of insulin-like growth factor i is associated with Ara-C resistance in leukemia. Tohoku J Exp Med (2006) 0.99
Glucocorticoids co-interact with lipoxin A4 via lipoxin A4 receptor (ALX) up-regulation. Biomed Pharmacother (2006) 0.99
Pancreas-sparing duodenectomy for duodenal neoplasms including malignancies. Hepatogastroenterology (2007) 0.98
Accelerated lymphangiogenesis in malignant lymphoma: possible role of VEGF-A and VEGF-C. Br J Haematol (2005) 0.98
Human umbilical cord-derived mesenchymal stromal cells differentiate into functional Schwann cells that sustain peripheral nerve regeneration. J Neuropathol Exp Neurol (2010) 0.98
Aryl hydrocarbon receptor is a transcriptional activator of the human breast cancer resistance protein (BCRP/ABCG2). Mol Pharmacol (2010) 0.98
Extrahepatic portal vein occlusion without recurrence after pancreaticoduodenectomy and intraoperative radiation therapy. Int J Radiat Oncol Biol Phys (2005) 0.97
FLT3-ITD induces ara-C resistance in myeloid leukemic cells through the repression of the ENT1 expression. Biochem Biophys Res Commun (2009) 0.96
The carboxyl-terminal region of erythroid-specific 5-aminolevulinate synthase acts as an intrinsic modifier for its catalytic activity and protein stability. Exp Hematol (2012) 0.96
Radiofrequency ablation for hepatocellular carcinoma induces glypican-3 peptide-specific cytotoxic T lymphocytes. Int J Oncol (2011) 0.96
Duodenal follicular lymphoma lacks AID but expresses BACH2 and has memory B-cell characteristics. Mod Pathol (2012) 0.96
Solitary bile duct hamartoma of the liver. Scand J Gastroenterol (2005) 0.96
Fratricide of natural killer cells dressed with tumor-derived NKG2D ligand. Proc Natl Acad Sci U S A (2013) 0.95
Differential expression of leukotriene B4 receptor subtypes (BLT1 and BLT2) in human synovial tissues and synovial fluid leukocytes of patients with rheumatoid arthritis. J Rheumatol (2003) 0.95
Identification of a novel erythroid-specific enhancer for the ALAS2 gene and its loss-of-function mutation which is associated with congenital sideroblastic anemia. Haematologica (2013) 0.95
Clinicopathological features of stomach cancer with invasive micropapillary component. Gastric Cancer (2011) 0.95
Clinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice. Rheumatol Int (2009) 0.94
Plasmodium falciparum FIKK kinase members target distinct components of the erythrocyte membrane. PLoS One (2010) 0.94
Predictive value of baseline neutrophil/lymphocyte ratio for T4 disease in wall-penetrating gastric cancer. World J Surg (2011) 0.94
Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis. J Rheumatol (2007) 0.94
Late-onset X-linked sideroblastic anemia following hemodialysis. Blood (2003) 0.94
Autoimmune pancreatitis with multifocal lesions. J Hepatobiliary Pancreat Surg (2008) 0.93
Stanniocalcin-1 as a novel marker to detect minimal residual disease of human leukemia. Tohoku J Exp Med (2004) 0.93
Schematic pancreatic configuration: a risk assessment for postoperative pancreatic fistula after pancreaticoduodenectomy. J Gastrointest Surg (2013) 0.93
Over-expression of Flt3 induces NF-kappaB pathway and increases the expression of IL-6. Leuk Res (2005) 0.93
The GATA1 mutation in an adult patient with acute megakaryoblastic leukemia not accompanying Down syndrome. Blood (2004) 0.92
Aggressive multimodal treatment for peritoneal dissemination and needle tract implantation of hepatocellular carcinoma: a case report. Jpn J Clin Oncol (2004) 0.92
Volume reduction surgery for advanced hepatocellular carcinoma. J Cancer Res Clin Oncol (2004) 0.92
T-cell prolymphocytic leukemia in Japan: is it a variant? Int J Hematol (2012) 0.91
Assessment of RAISUS, a novel system for identification and antimicrobial susceptibility testing for enterococci. Diagn Microbiol Infect Dis (2005) 0.91
The Flt3 internal tandem duplication mutant inhibits the function of transcriptional repressors by blocking interactions with SMRT. Blood (2004) 0.91
Pathophysiology and genetic mutations in congenital sideroblastic anemia. Pediatr Int (2013) 0.91
Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas. Pancreas (2010) 0.91
Quality assessment of umbilical cord blood units at the time of transplantation. Int J Hematol (2011) 0.91
Successful use of intensive immunosuppressive therapy for treating simultaneously occurring cerebral lesions and pulmonary arterial hypertension in a patient with systemic lupus erythematosus. Intern Med (2014) 0.90
Postoperative serum alpha-fetoprotein level is a useful predictor of recurrence after hepatectomy for hepatocellular carcinoma. Oncol Rep (2010) 0.90
Lipopolysaccharide-induced up-regulation of triggering receptor expressed on myeloid cells-1 expression on macrophages is regulated by endogenous prostaglandin E2. J Immunol (2007) 0.90
Prognostic value of cytologic examination of peritoneal washings in pancreatic cancer. Arch Surg (2002) 0.90
Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS). Ann Hematol (2012) 0.90
Intraductal oncocytic papillary neoplasm of the pancreas with strong accumulation on FDG-PET. Hepatogastroenterology (2008) 0.90
Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type. Leuk Lymphoma (2010) 0.90
Anesthetic management for ascending aorta replacement in a patient who refused autologous transfusion for religious reasons. J Anesth (2009) 0.89
Safety and feasibility of high-dose ranimustine (MCNU), carboplatin, etoposide, and cyclophosphamide (MCVC) therapy followed by autologous stem cell transplantation for malignant lymphoma. Int J Hematol (2012) 0.89
A new complex translocation t(5;17;15)(q11;q21;q22) in acute promyelocytic leukemia. Cancer Genet Cytogenet (2008) 0.89
Reduced angiogenesis and delay in wound healing in angiotensin II type 1a receptor-deficient mice. Biomed Pharmacother (2009) 0.89
3-Deazaneplanocin A (DZNep), an inhibitor of S-adenosylmethionine-dependent methyltransferase, promotes erythroid differentiation. J Biol Chem (2014) 0.89
The differentiating and apoptotic effects of 2-aza-5'-deoxycytidine are dependent on the PU.1 expression level in PU.1-transgenic K562 cells. Biochem Biophys Res Commun (2012) 0.89
Risk factors of surgical site infection after hepatectomy for liver cancers. World J Surg (2009) 0.88
Pretreatment of Pseudomonas aeruginosa with a sub-MIC of imipenem enhances bactericidal activity of neutrophils. J Infect Chemother (2003) 0.88
Human parvovirus B19 infection during the inactive stage of systemic lupus erythematosus. Intern Med (2003) 0.88
Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study. Cancer Sci (2009) 0.88
Adenocarcinoma of the minor duodenal papilla with intraepithelial spread to the pancreatic duct. Virchows Arch (2007) 0.88
Short-term outcome of total laparoscopic distal gastrectomy for overweight and obese patients with gastric cancer. Surg Endosc (2013) 0.87
Retrovirally introduced prostaglandin D2 synthase suppresses lung injury induced by bleomycin. Am J Respir Cell Mol Biol (2003) 0.87
Flt3 mutation activates p21WAF1/CIP1 gene expression through the action of STAT5. Biochem Biophys Res Commun (2004) 0.87
Gene expression profiling identifies HOXB4 as a direct downstream target of GATA-2 in human CD34+ hematopoietic cells. PLoS One (2012) 0.87
Acquired hemophilia A with sigmoid colon cancer: successful treatment with rituximab followed by sigmoidectomy. Int J Hematol (2009) 0.87
Inverse correlation between Flt3 and PU.1 expression in acute myeloblastic leukemias. Leuk Res (2005) 0.87
Involvement of osteopontin and its signaling molecule CD44 in clinicopathological features of adult T cell leukemia. Leuk Res (2011) 0.87
Multiple palmar epidermoid cysts. Dermatology (2002) 0.87
Evaluation of the BD Phoenix SMIC/ID, a new streptococci identification and antimicrobial susceptibility panel, for potential routine use in a university-based clinical microbiology laboratory. Diagn Microbiol Infect Dis (2005) 0.86
Thromboxane A₂ receptor signaling facilitates tumor colonization through P-selectin-mediated interaction of tumor cells with platelets and endothelial cells. Cancer Sci (2012) 0.86